Amplia Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
narmafotinib (AMP945) / Amplia Therap
ACCENT, NCT05355298: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer

Recruiting
1/2
62
RoW
AMP945 ascending doses, AMP945 RP2D
Amplia Therapeutics Limited
Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma
05/25
05/25
ACTRN12620000894998p: A Phase I, randomised, double blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of single and repeat doses of AMP945 administered orally to healthy adult volunteers

Not yet recruiting
1
64
 
Amplia Therapeutics Limited, Amplia Therapeutics Limited
Pancreatic cancer; Idiopathic pulmonary fibrosis
 
 
AMP886 / Amplia Therap
No trials found

Download Options